Anti-VE-cadherin mAbs (ImClone)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameAnti-VE-cadherin mAbs (ImClone)
Drug Alias Name19E6 mAb10G4E4G10BV-13
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCadherins inhibitorsAngiogenesis inhibitorsMetastasis inhibitors
TargetsCadherins
Therapy Area/IndicationsSolid tumoursAngiogenesis disorderNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImclone Systems
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImclone Systems
Active IndicationsN/A
Inactive IndicationsSolid tumoursAngiogenesis disorderNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A